A Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer

NCT01304602 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Irinotecan
DRUG: BKM120

Sponsor

University of Kansas Medical Center